Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jul 30;4(4):e00250-13.
doi: 10.1128/mBio.00250-13.

Clade-specific virulence patterns of Mycobacterium tuberculosis complex strains in human primary macrophages and aerogenically infected mice

Affiliations

Clade-specific virulence patterns of Mycobacterium tuberculosis complex strains in human primary macrophages and aerogenically infected mice

Norbert Reiling et al. mBio. .

Abstract

In infection experiments with genetically distinct Mycobacterium tuberculosis complex (MTBC) strains, we identified clade-specific virulence patterns in human primary macrophages and in mice infected by the aerosol route, both reflecting relevant model systems. Exclusively human-adapted M. tuberculosis lineages, also termed clade I, comprising "modern" lineages, such as Beijing and Euro-American Haarlem strains, showed a significantly enhanced capability to grow compared to that of clade II strains, which include "ancient" lineages, such as, e.g., East African Indian or M. africanum strains. However, a simple correlation of inflammatory response profiles with strain virulence was not apparent. Overall, our data reveal three different pathogenic profiles: (i) strains of the Beijing lineage are characterized by low uptake, low cytokine induction, and a high replicative potential, (ii) strains of the Haarlem lineage by high uptake, high cytokine induction, and high growth rates, and (iii) EAI strains by low uptake, low cytokine induction, and a low replicative potential. Our findings have significant implications for our understanding of host-pathogen interaction and factors that modulate the outcomes of infections. Future studies addressing the underlying mechanisms and clinical implications need to take into account the diversity of both the pathogen and the host.

Importance: Clinical strains of the Mycobacterium tuberculosis complex (MTBC) are genetically more diverse than previously anticipated. Our analysis of mycobacterial growth characteristics in primary human macrophages and aerogenically infected mice shows that the MTBC genetic differences translate into pathogenic differences in the interaction with the host. Our study reveals for the first time that "TB is not TB," if put in plain terms. We are convinced that it is very unlikely that a single molecular mechanism may explain the observed effects. Our study refutes the hypothesis that there is a simple correlation between cytokine induction as a single functional parameter of host interaction and mycobacterial virulence. Instead, careful consideration of strain- and lineage-specific characteristics must guide our attempts to decipher what determines the pathological potential and thus the outcomes of infection with MTBC, one of the most important human pathogens.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Cytokine release of human macrophages in response to infection with strains of the MTBC. hMDMs were infected with the indicated strains of the MTBC with an MOI of 3:1 for 24 h. The release of TNF, IL12p40, IL-1β, IL-6, and RANTES was measured by cytometric bead array analysis (BD Bioscience). Means ± SE for three independent donors are shown. To adjust for donor-specific response levels, data have been normalized to the lipopolysaccharide (LPS) (10 ng/ml) responses of the donors (=100%).
FIG 2
FIG 2
Differential uptake of MTBC strains by human macrophages. hMDMs were infected with strains of different lineages of the MTBC with an MOI of 1:1 for 4 h. Quantification of viable CFU of the inoculum and 4 h postinfection was conducted by lysis of monolayers, serial dilution, and plating on 7H10 medium. Shown is the uptake (%) of bacteria related to the inoculum of each individual strain (mean ± SE for three independent experiments performed). Strains were grouped into lineages, and the uptake rates were compared by one-way analysis of variance (ANOVA); Tukey multiple-comparison test, **, P < 0.01).
FIG 3
FIG 3
Differential growth of MTBC strains in human macrophages. (A) hMDMs were infected with the indicated strains of different lineages of the MTBC with an MOI of 1:1 for 4 h and 7 days. Quantification of viable CFU at 4 h and 7 days postinfection was conducted by lysis of monolayers, serial dilution, and plating on 7H10 medium. Error bars indicate standard errors of the means from three independent experiments performed with cells from different donors, each consisting of two technical replicates per strain. The mean of the fold increase is shown in the upper left corner of each graph. (B) Fold growth of MTBC clade I and clade II in human macrophages. Shown are the means ± SEM of all clade I and II strains analyzed in panel A (*, P < 0.05, Mann-Whitney U test).
FIG 4
FIG 4
Differential growth of MTBC strains in human bronchoalveolar cells. Cells isolated from bronchoalveolar lavage of healthy donors were infected with the indicated strains of different lineages of the MTBC with an MOI of 1:1 for 4 h and 7 days. Quantification of viable CFU at 4 h and 7 days postinfection was conducted by lysis of monolayers, serial dilution, and plating on 7H10 medium. Error bars indicate standard deviations for two independent experiments performed with cells from different donors, each consisting of two technical replicates per strain.
FIG 5
FIG 5
Growth of different MTBC Haarlem strains in human macrophages. hMDMs were infected with the indicated strains of different lineages of the MTBC with an MOI of 1:1 for 4 h and 7 days. Quantification of viable CFU at 4 h and 7 days postinfection was conducted by lysis of monolayers, serial dilution, and plating on 7H10 medium. Error bars indicate standard errors of the means for three independent experiments performed with cells from different donors, each consisting of two technical replicates per strain. The mean fold increase is shown in the upper left corner of each graph.
FIG 6
FIG 6
Virulence of selected genotypes of the MTBC in mice. Detection of bacterial replication in the lung (A) or survival time (B) after aerosol infection with an intended infection dose of 200 CFU of representative strains of the EAI (filled triangles, dot-dash line) and Beijing (filled squares, dotted line) genotypes and H37Rv (empty circles, continuous line) as the reference strain. The bacterial burden was analyzed in the lungs of C57BL/6 mice; the survival time after infection with these strains was monitored in DBA/2 mice. Determination of the inoculum size revealed that mice were infected with 588 CFU of the H37Rv strain, which is 1.7× higher than the infection dose of the EAI (345 CFU) and 3.7× higher than the inoculum size of the Beijing (159 CFU) genotype. In order to allow a better comparison of the bacterial replication and survival time between the three genotypes, results from a parallel infection experiment with an inoculum size of 128 CFU of the H37Rv strain are included (filled circles, continuous line). Statistics: for CFU determination, data were log transformed and analyzed by two-way ANOVA with a Bonferroni posthoc test; ****, P < 0.0001; survival, log-rank Mantel Cox test; ****, P < 0.0001; ***, P < 0.0005.
FIG 7
FIG 7
Histology of lungs infected with selected genotypes of the MTBC. Representative histopathological findings for the lungs at 21 and 90 days after aerosol infection with isolates of the Beijing (A and B, d21; G and H, d90) or EAI (C and D, d21; I and J, d90) genotype and H37Rv (E and F, d21; K and L, d90) as a reference strain (intended infection dose, 200 CFU). Sections of the lungs were stained with H&E and are shown at low (×40) (A, C, E, G, K, and L) or higher (×100) (B, D, F, H, I, and J) magnification, respectively. Scale bars, 100 µm.

Similar articles

Cited by

References

    1. WHO 2012. Global tuberculosis report 2012. WHO, Geneva, Switzerland
    1. Gagneux S, Small PM. 2007. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect. Dis. 7:328–337 - PubMed
    1. Wirth T, Hildebrand F, Allix-Béguec C, Wölbeling F, Kubica T, Kremer K, van Soolingen D, Rüsch-Gerdes S, Locht C, Brisse S, Meyer A, Supply P, Niemann S. 2008. Origin, spread and demography of the Mycobacterium tuberculosis complex. PLoS Pathog. 4:e1000160 http://dx.doi.org/doi:10.1371/journal.ppat.1000160 - PMC - PubMed
    1. Hershberg R, Lipatov M, Small PM, Sheffer H, Niemann S, Homolka S, Roach JC, Kremer K, Petrov DA, Feldman MW, Gagneux S. 2008. High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography. PLoS Biol. 6:e311.10.1371/journal.pbio.0060311 - DOI - PMC - PubMed
    1. Comas I, Chakravartti J, Small PM, Galagan J, Niemann S, Kremer K, Ernst JD, Gagneux S. 2010. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat. Genet. 42:498–503 - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources